Replimune Group Book Value Per Share Growth & History (REPL)
Replimune Group's book value per share was $2.01 for fiscal 2026.
View full Replimune Group company overviewReplimune Group annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $2.01 | -$3.39 | −62.76% |
| 2025 | 2025-03-31 | $5.39 | -$0.70 | −11.53% |
| 2024 | 2024-03-31 | $6.10 | -$3.70 | −37.76% |
| 2023 | 2023-03-31 | $9.80 | $1.11 | +12.79% |
| 2022 | 2022-03-31 | $8.69 | -$2.02 | −18.89% |
| 2021 | 2021-03-31 | $10.71 | $5.70 | +113.76% |
| 2020 | 2020-03-31 | $5.01 | $0.66 | +15.05% |
| 2019 | 2019-03-31 | $4.35 | $9.96 | — |
| 2018 | 2018-03-31 | -$5.61 | -$3.29 | — |
| 2017 | 2017-03-31 | -$2.32 | — | — |
Replimune Group quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $1.26 | -$3.07 | −70.93% |
| Q4 2026 | 2026-03-31 | $2.01 | -$3.39 | −62.76% |
| Q3 2026 | 2025-12-31 | $2.64 | -$3.62 | −57.79% |
| Q2 2026 | 2025-09-30 | $3.36 | -$2.22 | −39.78% |
| Q1 2026 | 2025-06-30 | $4.33 | -$1.92 | −30.68% |
| Q4 2025 | 2025-03-31 | $5.39 | -$0.70 | −11.53% |
| Q3 2025 | 2024-12-31 | $6.26 | -$0.60 | −8.78% |
| Q2 2025 | 2024-09-30 | $5.58 | -$2.30 | −29.19% |
| Q1 2025 | 2024-06-30 | $6.24 | -$2.47 | −28.37% |
| Q4 2024 | 2024-03-31 | $6.10 | -$3.70 | −37.76% |
| Q3 2024 | 2023-12-31 | $6.87 | -$3.65 | −34.68% |
| Q2 2024 | 2023-09-30 | $7.88 | $0.15 | +2.00% |
| Q1 2024 | 2023-06-30 | $8.72 | $0.39 | +4.73% |
| Q4 2023 | 2023-03-31 | $9.80 | $1.11 | +12.79% |
| Q3 2023 | 2022-12-31 | $10.51 | $1.24 | +13.43% |
| Q2 2023 | 2022-09-30 | $7.72 | -$2.04 | −20.90% |
| Q1 2023 | 2022-06-30 | $8.32 | -$1.93 | −18.82% |
| Q4 2022 | 2022-03-31 | $8.69 | -$2.02 | −18.89% |
| Q3 2022 | 2021-12-31 | $9.27 | -$1.86 | −16.72% |
| Q2 2022 | 2021-09-30 | $9.76 | $3.28 | +50.56% |
| Q1 2022 | 2021-06-30 | $10.25 | $3.35 | +48.63% |
| Q4 2021 | 2021-03-31 | $10.71 | $5.70 | +113.76% |
| Q3 2021 | 2020-12-31 | $11.13 | $5.74 | +106.42% |
| Q2 2021 | 2020-09-30 | $6.48 | $2.68 | +70.48% |
| Q1 2021 | 2020-06-30 | $6.90 | $2.79 | +67.79% |
| Q4 2020 | 2020-03-31 | $5.01 | $0.66 | +15.05% |
| Q3 2020 | 2019-12-31 | $5.39 | $0.86 | +19.09% |
| Q2 2020 | 2019-09-30 | $3.80 | -$0.95 | −20.01% |
| Q1 2020 | 2019-06-30 | $4.11 | $11.84 | — |
| Q4 2019 | 2019-03-31 | $4.35 | $9.96 | — |
| Q3 2019 | 2018-12-31 | $4.53 | — | — |
| Q2 2019 | 2018-09-30 | $4.75 | — | — |
| Q1 2019 | 2018-06-30 | -$7.73 | — | — |
| Q4 2018 | 2018-03-31 | -$5.61 | — | — |
Replimune Group book value per share trends
Over the last five fiscal years, Replimune Group's book value per share decreased from $10.71 to $2.01, a change of -$8.70. The latest reported quarter, Q1 2027, shows $1.26.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Replimune Group source filings ↗